VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 14 filers reported holding VANECK VECTORS ETF TR in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,392,128 | -48.1% | 497,665 | -49.4% | 0.60% | +6.2% |
Q2 2023 | $25,805,822 | +6952.5% | 984,488 | +5902.2% | 0.57% | +3443.8% |
Q1 2023 | $365,911 | +45298.4% | 16,402 | -54.8% | 0.02% | -27.3% |
Q4 2022 | $806 | -99.9% | 36,259 | -8.1% | 0.02% | -4.3% |
Q3 2022 | $879,000 | +12.1% | 39,435 | +12.2% | 0.02% | -8.0% |
Q2 2022 | $784,000 | -8.9% | 35,155 | -8.8% | 0.02% | +127.3% |
Q1 2022 | $861,000 | +2000.0% | 38,537 | +3051.0% | 0.01% | +1000.0% |
Q4 2021 | $41,000 | -54.9% | 1,223 | -59.6% | 0.00% | -50.0% |
Q3 2021 | $91,000 | -68.1% | 3,030 | -63.8% | 0.00% | -66.7% |
Q2 2021 | $285,000 | +190.8% | 8,376 | +179.8% | 0.01% | +200.0% |
Q1 2021 | $98,000 | -52.2% | 2,994 | -48.0% | 0.00% | -75.0% |
Q4 2020 | $205,000 | -78.6% | 5,754 | -76.7% | 0.01% | -86.0% |
Q3 2020 | $958,000 | +20.5% | 24,669 | +8.7% | 0.06% | -9.5% |
Q2 2020 | $795,000 | +846.4% | 22,686 | +592.3% | 0.06% | +687.5% |
Q1 2020 | $84,000 | -99.2% | 3,277 | -99.1% | 0.01% | -99.0% |
Q4 2019 | $10,317,000 | +18.0% | 357,716 | +12.4% | 0.78% | +32.3% |
Q3 2019 | $8,740,000 | +836.8% | 318,344 | +663.2% | 0.59% | +361.4% |
Q1 2019 | $933,000 | +34.6% | 41,713 | +23.9% | 0.13% | +202.4% |
Q4 2018 | $693,000 | -1.4% | 33,660 | -11.3% | 0.04% | +44.8% |
Q3 2018 | $703,000 | -40.7% | 37,956 | -28.5% | 0.03% | -42.0% |
Q2 2018 | $1,185,000 | +40.4% | 53,096 | +46.2% | 0.05% | +31.6% |
Q1 2018 | $844,000 | 0.0% | 36,326 | 0.0% | 0.04% | 0.0% |
Q4 2017 | $844,000 | -9.9% | 36,326 | -11.0% | 0.04% | +2.7% |
Q3 2017 | $937,000 | +5.8% | 40,824 | +1.8% | 0.04% | -2.6% |
Q2 2017 | $886,000 | -5.7% | 40,116 | -2.7% | 0.04% | -7.3% |
Q1 2017 | $940,000 | -30.4% | 41,215 | -36.2% | 0.04% | -36.9% |
Q4 2016 | $1,351,000 | -65.8% | 64,600 | -56.8% | 0.06% | -68.4% |
Q3 2016 | $3,955,000 | +17.1% | 149,640 | +22.8% | 0.21% | +9.0% |
Q2 2016 | $3,377,000 | +262.0% | 121,886 | +192.2% | 0.19% | +48.8% |
Q1 2016 | $933,000 | – | 41,713 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |